Calls for Proposals Early-stage Female FY 2020 Infectious Diseases and Immunology Research: U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards, 2020
※Updated on March 19, 2020; Submission Deadline has been extended due to the COVID-19 outbreak in U.S.
2019.11.14 Thu - 2020.3.31 Tue (12:59 pm) Japan Time (UCT +9)
※Updated on March 17, 2020; Submission Deadline has been extended due to the COVID-19 outbreak in U.S.
2019.11.14 Thu - 2020.3.24 Tue (13:00 pm) Japan Time (UCT +9)
※Updated on November 18, 2019; "Supplemental Application Guideline for Japanese Sub-teams (in Japanese) " Page 6（e-Rad submission period）,10-45
|Status of Grants/Funding Opportunities||Grants/Funding Opportunities|
|R&D phase||Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, Clinical Research|
|Key Fields||Emerging/ Re-Emerging Infectious Disease Project Of Japan(1st), Other programs(1st)|
|Submission Deadline||2020.3.31 Tue (12:59 pm)|
Public offering content
Japan Agency for Medical Research and Development (AMED), in collaboration with U.S. National Institute of Allergy and Infectious Diseases (NIAID), is pleased to announce the joint request for proposals on "Infectious Diseases and Immunology Research: US-Japan Cooperative Medical Sciences Program Collaborative Awards, 2020."
Awardees are expected to present their achievements at International Conference on Emerging Infectious Diseases in the Pacific Rim after 2021.
- (1) Research areas
- Infectious Diseases and Immunology
- (2) Project size
- 60,000 USD
AMED needs to contract with the Japan sub teams in every fiscal year. 50 % of the total research budget is granted in JFY 2020, and of the research budget (50%) is granted in 2nd fiscal year, in JFY 2021.
- (3) Research period
- JFY 2020~JFY 2021
- (4) Number of projects to be awarded
- 0-6 projects (expected)
For details please refer to the complete Request for Proposals:
Overview of US-Japan Cooperative Medical Sciences Program
The US-Japan Cooperative Medical Sciences Program (USJCMSP), one of the oldest bilateral programs in the history of, was established in 1965 (under a U.S. Presidential-Japan Prime Ministerial level agreement) to strengthen Japanese research capacity and address issues of public health importance in the Asia Pacific region. The program continues to maintain its value as a unique tool to foster U.S., Japan, and Asia Pacific Region research collaboration. For more
- Collaborative research teams consisting of investigators from (1) Japan and the U.S. , or (2) Japan, the U.S., and other Asia Pacific countries, are eligible to apply.
- On each application both of the Japanese sub-team and the U.S sub team must include as a PI an early-stage or female investigator.
For complete eligibility requirements, please refer to the Request for Proposals.
In addition to the submission through CRDF Global's application portal, applicants to AMED are required to complete e-Rad submission no later than Tuesday, March 31, 2020 (12:59 pm) in Japan Standard Time.
How to Apply
To apply, please follow the information on the Request for Proposals and the AMED Supplemental Application Guideline for Japanese Sub-teams (in Japanese).
Last updated 2020.3.19